Home
About us
Pronova BioPharma in brief
Production facilities
History
Our business concept
Vision, values and strategy
Ethical guidlines
Health, safety and environment
Human resources
Management team
Board of directors
Product
Omacor/Lovaza
Production process
Market
Distribution and partners
Research & development
Approach to R&D
R&D programs
Quality
Ensuring excellent quality
Quality Control
Quality Assurance
Audit programs
Pharmacovigilance
News
Press releases archive
Media
Media contact
Fact sheet
Fact sheet in Norwegian
Photo archive
Investors
The share
Stock market announcements
Reports and presentations
Financial calendar
Shareholder information
Top 20 shareholders
Policies
Dividend policy
Investor relations policy
Articles of association
General meeting
Registrar
Corporate governance
Analytical coverage
Subscribe
Contact information IR
Careers
General application
What we offer
Meet some of our people
Vacancies
Contact
Contact details
Henvendelser om Omacor i Norge
You are here:
Home
/
News
Førsteklasses produksjonsresultater ga god start på 2009
Read more
Press releases
5. Jul 2010 09:07:
Adds another patent to the Orange Book listing of Omacor®/Lovaza(TM)
16. Jun 2010 15:15:
Mandatory notification of trade
15. Jun 2010 10:09:
Mandatory notification of trade
14. Jun 2010 08:34:
Pronova BioPharma revises shipment outlook for 2010
3. Jun 2010 16:10:
Guidelines for remuneration to senior management
7. May 2010 13:57:
Minutes from the ordinary general meeting
7. May 2010 07:00:
Strengthened position following intellectual property and regulatory approvals
27. Apr 2010 14:32:
Presentation of first quarter 2010 results
Press releases archive
Copyright 2007
©
Pronova BioPharma ASA
idium
web publishing
